GLP-1 Key Research Facts Full name: Glucagon-Like Peptide-1 incretin hormone of the proglucagon family Primary bioactive form: GLP-1(736)amide 30 amino acids, C-terminally amidated Gene source: Proglucagon gene processed by PCSK1 in intestinal L-cells and brainstem NTS neurons In vivo half-life: Approximately 12 minutes rapidly inactivated by DPP-4 (cleaves His7-Ala8 dipeptide) Primary receptor: GLP-1R (GLP-1 receptor) class B G protein-coupled receptor (GPCR) Signalling: GLP-1R activation cAMP elevation PKA/CREB activation glucose-dependent insulin secretion Additional signalling: PI3K/Akt pathway -cell survival, proliferation, and glucose sensitivity Secretion pattern: Biphasic post-meal release from intestinal L-cells early neural/endocrine peak + late direct nutrient-contact peak Fasting plasma level: ~510 pmol/L
A1C testing at the three-month mark provides the first reliable assessment of the medications impact on average glucose control
Please confirm the statements below
Then, you'll be prompted to answer a questionnaire, which asks you to disclose if you've ever enrolled in a weight loss program before, if you have family members with weight struggles, and other similar questions
No insurance required TrimRx money-back guarantee Transparent pricing
What derails progress: common pitfalls in before and after stories Dramatic before and after transformations grab attention, but many tirzepatide users achieve modest results or abandon treatment early